Study to Determine and Compare Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam in Healthy Subjects
Clinical trial NCT03303924 · COMPLETED
Trial details
- NCT number
- NCT03303924
- Sponsor
- Entasis Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-21
- Primary completion
- 2017-10-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.